Uswm Ct, Llc
Clinical trials sponsored by Uswm Ct, Llc, explained in plain language.
-
Engineered immune cells tested against childhood cancers
Disease control Recruiting nowThis study tests a new treatment called afamitresgene autoleucel for children and young adults aged 2 to 21 with certain advanced cancers (synovial sarcoma, MPNST, neuroblastoma, or osteosarcoma). The treatment uses the patient's own immune cells that are modified in a lab to rec…
Phase: PHASE1, PHASE2 • Sponsor: USWM CT, LLC • Aim: Disease control
Last updated May 01, 2026 15:59 UTC
-
15-Year watch begins for cell therapy recipients
Knowledge-focused Recruiting nowThis study follows up to 250 people who have already received ADP adoptive cell therapy for cancer. Researchers will track delayed side effects and serious health events for up to 15 years after the last treatment. The goal is to understand the long-term safety of this therapy, n…
Phase: PHASE1 • Sponsor: USWM CT, LLC • Aim: Knowledge-focused
Last updated May 01, 2026 15:57 UTC